Squamous Cell Carcinoma In Situ
Avi Israel Einzig
Susanna Curtis
Mark H. Chaitowitz
<p>Dr. Mark Chaitowitz obtained his medical degree at the University of Witwatersrand in Johannesburg, South Africa. He relocated to the United States in 2001, where he completed his residency in internal medicine at Albert Einstein Medical Center, and fellowship in hematology and oncology at Thomas Jefferson University Hospital, both in Philadelphia.</p>
<p>In 2013 Dr. Chaitowitz joined the Division of Hematology as an Assistant Professor. He sees patients with a wide range of blood disorders, both benign and malignant. He has a special interest in platelet disorders, as well as in the management of iron deficiency anemia, his area of clinical research.</p>
<ol>
<li>Zheng, C. Y. Minniti, C. P. Chaitowitz, M. H., Sickle cell crisis complicated by synthetic cannabinoid abuse: a case report, Hemoglobin, 2016, accepted for publication.</li>
<li>Scott, E., U. Borate, S. Heitner, M. Chaitowitz, W. Tester, and G. Eiger, Pain Management Practices by Internal Medicine Residents: A Comparison Before and After Educational and Institutional Interventions, American Journal of Hospice and Palliative Medicine, 2009; 25(6): 431-439. </li>
<li>Chaitowitz, M. H., A. Ferber and N. Flomenberg, Patient-reported experience of chemotherapy: expectations vs. reality, Journal of Clinical Oncology, 2008; 26 (May 20 suppl; abstr 20686).</li>
<li>Darabi, K. Sieber, M. Chaitowitz, M. Braitman, L. Tester, W. Diehl, V. Infradiaphragmatic versus supradiaphragmatic Hodgkin lymphoma: A retrospective review of 1,114 patients. Leukemia and Lymphoma, 2005; 46(12): 1715-1720. </li>
<li>Chaitowitz, M., W. Tester and G. Eiger, Use of a comprehensive survey as a first step in addressing clinical competence of physicians-in-training in the management of pain, Journal of Opioid Management, 2005 May/June; 98-108.</li>
<li>Chaitowitz, M., M.L. Shaw and T.R. Mokoena, Gastrointestinal cryptococcosis presenting as spontaneous jejunal perforation in a nonimmunocompromised host, Digestive Disease and Science, 2003; 48(6): 1196-1199.</li>
</ol>
Enrico Castellucci
Anne Barmettler
<p>Specialization in eyelids, orbit, and lacrimal system and treatment of conditions, such as:</p><ul><li>Eyelid malposition (i.e. entropion, ectropion, retraction)</li><li>Benign and malignant eyelid tumors</li><li>Periocular skin lesions and chalazia (styes)</li><li>Eyelid reconstruction</li><li>Ptosis (drooping eyelids) and dermatochalasis (excess eyelid skin)</li><li>Brow ptosis (drooping eyebrows)</li><li>Facial rejuvenation (Botox, fillers, lasers, aesthetic eyelid and forehead surgery)</li><li>Puffy eyelids</li><li>Orbital (eye socket) tumors and inflammatory syndromes</li><li>Thyroid (Graves') Eye Disease</li><li>Eyelid, orbital and lacrimal system trauma</li><li>Tearing secondary to nasolacrimal duct obstruction, punctal or canalicular stenosis, and eyelid malposition</li><li>Congenital orbital and eyelid abnormalities</li></ul>
<p>Dr. Barmettler is a dedicated researcher and educator. Along with writing numerous papers and textbook chapters, she is routinely invited to give lectures and presentations at national meetings.</p>
<p>Anne Barmettler, MD, is Director, Plastic and Reconstructive Surgery Division and Professor, Ophthalmology and Visual Sciences and Surgery at Montefiore Einstein. Dr. Barmettler’s clinical specialty is oculoplastic surgery, which involves plastic and reconstructive surgery of the upper face, eyelids, orbit (bony cavity around the eye), and lacrimal (tear) system.</p><p>After earning her Bachelor of Arts in biochemistry at Bowdoin College in 2003, Dr. Barmettler pursued her Doctor of Medicine at Thomas Jefferson University, Jefferson Medical College, earning the degree in 2008. Her postdoctoral training began with a yearlong internship at Crozer Chester Medical Center, which she completed in 2009 before beginning a three-year residency in ophthalmology at New York Presbyterian Weill Cornell Medical College. She then undertook a competitive two-year fellowship in ophthalmic plastic and reconstructive surgery from 2012 to 2014, training at William Beaumont Hospital, Kresge Eye Institute at Wayne State University and Consultants in Ophthalmic Facial Plastic Surgery.</p><p>Dr. Barmettler's research builds on her clinical interests in the treatment of conditions of the eyelid, orbit and lacrimal system. She has published over 50 peer-reviewed articles of original research, textbook chapters and review papers. She is routinely invited to give lectures and presentations at national and international meetings. Dr. Barmettler has been recognized for her dedication to research and now acts on the editorial board for the American Society of Ophthalmic Plastic and Reconstructive Surgery's journal of <em>Ophthalmic Plastic and Reconstructive Surgery</em>. She also serves as Editor for the American Academy of Ophthalmology website, Eyewiki, and is a peer-reviewer for many journals, including <em>JAMA Ophthalmology, Facial Plastic Surgery and Aesthetic Medicine, Orbit, BMJ Open, American Journal of Ophthalmology Case Reports</em>, and <em>Clinical Ophthalmology</em>.</p><p>Dr. Barmettler is board certified and a member of numerous professional organizations, including the American Academy of Ophthalmology, American Society of Ophthalmic Plastic and Reconstructive Surgery, Asian Pacific Academy of Ophthalmology, New York Ophthalmological Society, and the North American Society of Academic Orbital Surgeons. She is one of only 800 surgeons that are a member of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), passing both written and oral exams and a peer-reviewed thesis on spacer graft in lower eyelid retraction surgery. This research was recognized by the official national ophthalmology society and the American Academy of Ophthalmology, being awarded “Best of ASOPRS" in 2017.</p>
Bijal D. Amin
Dr. Amin’s clinical focus is on the study of tissue to diagnose inflammatory and neoplastic diseases of the skin.
Dr. Amin’s research focus follows her clinical interests in dermatopathology.
<p>Bijal Amin, MD, Associate Professor of Pathology and Internal Medicine, serves as the Director of the Dermatopathology and Program Director of the Dermatopathology Fellowship at Montefiore-Einstein. Dr. Amin’s clinical focus is on the study of tissue to diagnose inflammatory and neoplastic diseases of the skin.</p><p>Dr. Amin matriculated from the prestigious accelerated BA/MD program at the George Washington University School of Medicine. She started her postdoctoral training with an internship in internal medicine at University of Washington. She then went to NewYork-Presbyterian/Weill Cornell Medical Center for a residency in anatomic and clinical pathology from 2004 to 2008, acting as chief resident in pathology in her final year. In 2009, she completed a yearlong dermatopathology fellowship through a joint program with Memorial Sloan-Kettering Cancer Center and NewYork-Presbyterian/Weill Cornell. In 2020, she completed the Healthcare Information Technology certificate program at Columbia University. </p><p>Dr. Amin’s research focus follows her clinical interests in dermatopathology. Her work has been published in several peer-reviewed journals, book chapters, abstracts and presentations.</p>
<p>Dr. Amin is board certified and is a member of several professional societies including the College of American Pathologists and American Society of Dermatopathology. In 2015, she was awarded Teacher of the Year by Einstein’s Division of Dermatology. In addition to her work in dermatopathology, Dr. Amin has an interest in clinical informatics.</p>